Evidence map›Paper›PMID 40890721›Full record

SynthesisBMC medical informatics and decision making2025

Can artificial intelligence with multimodal imaging outperform traditional methods in predicting age-related macular degeneration progression? A systematic review and exploratory meta-analysis.

Kai-Yang Chen, Hoi-Chun Chan, Chi-Ming Chan

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kai-Yang ChenDepartment of General Medicine, Chang Gung Memorial Hospital (Linkou branch), Taoyuan, Taiwan.
Hoi-Chun ChanSchool of Pharmacy, China Medical University, Taichung, Taiwan.
Chi-Ming ChanDepartment of Ophthalmology, Cardinal Tien Hospital, New Taipei City, Taiwan. 068268@mail.fju.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAge-related macular degeneration (AMD) is a leading cause of irreversible vision loss, and its prevalence is expected to rise with aging populations. Early prediction of AMD progression is critical for effective management. This systematic review and meta-analysis evaluate the accuracy, sensitivity, and specificity of artificial intelligence (AI) algorithms in in detecting and predicting progression of AMD.

methodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic review and meta-analysis were conducted from inception to February 7th, 2025. We included five studies that assessed the performance of AI algorithms in predicting AMD progression using multimodal imaging. Data on accuracy, sensitivity, and specificity were extracted, and meta-analysis was performed using Comprehensive Meta-Analysis software version 3.7. Heterogeneity was assessed using the I² statistic.

resultsOf the five studies, AI models demonstrated superior accuracy (mean difference: 0.07, 95% CI: 0.07, 0.07; p < 0.00001) and sensitivity (mean difference: 0.08, 95% CI: 0.08, 0.08; p < 0.00001) compared to retinal specialists. Specificity also showed a minimal but significant advantage for AI (mean difference: 0.01, 95% CI: 0.01, 0.01; p < 0.00001). Importantly, heterogeneity was minimal to absent across all analyses (I² = 0–0.42%), supporting the reliability and consistency of pooled findings.

conclusionAI algorithms outperform retinal specialists in predicting AMD progression, particularly in accuracy and sensitivity. These findings support the potential of AI in AMD prediction; however, given the limited number of included studies, the results should be interpreted as exploratory and in need of validation through future large-scale, prospective studies.

Indexed as

Artificial IntelligenceDisease ProgressionMacular DegenerationMultimodal ImagingHumansPrediction AlgorithmsAge-related macular degenerationArtificial intelligenceDeep learningPredictive models

Identifiers

PMID40890721
PMCPMC12400700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.